Drug-resistant herpes simplex virus type 2 (HSV-2) strains were obtained under the selective pressure of acyclovir, ganciclovir, brivudin, foscamet, 2-phosphonyl-methoxyethyl (PME) derivatives of adenine (PMEA) and 2,6-diaminopurine (PMEDAP), and 3-hydroxy-2-phosphonylmethoxypropyl (HPMP) derivatives of adenine (HPMPA) and cytosine (HPMPC; cidofovir). A significant degree of cross-resistance between HPMPC and HPMPA on the one hand, and between PMEA, PMEDAP and foscarnet on the other, was noted, suggesting a different mode of interaction of the PME and HPMP derivatives at the DNA polymerase level. The results described here with HSV-2 agree with the published results for HSV-1 and human cytomegalovirus.
AndreiGSnoeckR & De ClercqE (1995) Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compounds. Antimicrobial Agents and Chemotherapy39:1632–1635.
2.
CoenDM (1996) Nucleosides and foscarnet. Mechanisms. In Antiviral Drug Resistance. Edited by RichmanDD. Chichester: John Wiley & Sons, pp. 81–102.
3.
CollinsP & DarbyG (1991) Laboratory studies of herpes simplex virus strains resistant to acyclovir. Reviews in Medical Virology1:19–28.
4.
CrumpackerCSSchnipperLEMarloweSIKowalskyPNHersheyBJ & LevinMJ (1982) Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. New England Journal of Medicine306:343–346.
5.
ErikssonBLarssonAHelgstrandEJohanssonNG & ÖbergB (1980) Pyrophosphate analogues as inhibitors of herpes simplex type 1 DNA polymerase. Biochimica et Biophysica Acta607:53–64.
6.
ErlichKSMillsJChatisPMertzGJBuschDFFollansbeeSEGrantRM & CrumpackerCS (1989) Acyclovir-resistant herpes simplex virus infections in patients with the acquired immuno deficiency syndrome. New England Journal of Medicine302:293–296.
7.
FieldAK & BironKK (1994) ‘The end of innocence’ revisited: resistance of herpesviruses to antiviral drugs. Clinical Microbiological Reviews7:1–13.
8.
LalezariJPDrewWLGlutzerEMinerDSafrinSOwenWFJrDavidsonJMFisherPE & JaffeHS (1994) Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propy]cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS. Journal of Infectious Diseases170:570–572.
9.
LalezariJPStaggRJKuppermannBDHollandGNKramerFIvesDVYouleMRobinsonMRDrewWL & JaffeHS (1997) Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Annals of Internal Medicine126:257–263.
10.
MendelDBBarkhimerDBKernER & ChenMS (1995) Isolation and initial characterization of a herpes simplex virus type 2 (HSV-2) strain with decreased sensitivity to cidofovir. Antiviral Research26:A312.
11.
NaesensLSnoeckRAndreiGBalzariniJNeytsJ & De ClercqE (1997) HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential in the treatment of viral infections. Antiviral Chemistry and Chemotherapy8:1–23.
12.
SafrinSAssaykeenTFollansbeeS & MillsJ (1990) Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data. Journal of Infectious Diseases161:1078–1084.
13.
SafrinSCrumpackerCSChatisPDavisRHafnerRRushJKesslerHALandryB & MillsJ (1991) A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. New England Journal of Medicine325:551–555.
14.
SafrinSKemmerlySPlotkinBSmithTWeissbachNDe VeranezDPhanLD & CohnD (1994) Foscarnet-resistant herpes simplex virus infection in patients with AIDS. Journal of Infectious Diseases169:193–196.
15.
SnoeckRAndreiGDe ClercqEGerardMClumeckNTricotG & Sadzot-DelvauxC (1993) A new topical treatment for resistant herpes simplex infections. New England Journal of Medicine329:968–969.
16.
SnoeckRAndreiGGerardMSilvermanAHeddermanABalzariniJSadzot-DelvauxCTricotGClumeckN & De ClercqE (1994) Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Clinical Infectious Diseases18:570–578.
17.
SnoeckRAndreiG & De ClercqE (1996) Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro. European Journal of Clinical Microbiology and Infectious Diseases15:574–579.
18.
VinckierFBoogaertsMDe ClerckD & De ClercqE (1987) Chronic herpetic infection in an immunocompromised patient: report of a case. Journal of Oral and Maxillofacial Surgery45:723–728.
